Endothelial Dysfunction in Obesity

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Adipose Tissue Biology

Background:

• Obesity causes chronic inflammation, disrupting vascular homeostasis and leading to endothelial dysfunction and hypertension.
• Perivascular adipose tissue (PVAT) in obesity releases altered adipokines, reducing its vasorelaxing effect and contributing to hypertension.
• Key factors in obesity-related endothelial dysfunction include adipose tissue inflammation, impaired nitric oxide (NO) bioavailability, insulin resistance, and oxidized low-density lipoprotein (oxLDL).

Purpose of the Study:

• To elucidate the mechanisms by which obesity-associated chronic inflammation disrupts vascular homeostasis.
• To explain the role of perivascular adipose tissue (PVAT) dysfunction in endothelial vasodilator impairment.
• To discuss the molecular factors contributing to endothelial dysfunction in the context of obesity.

Main Methods:

• Review of current literature on obesity, inflammation, and vascular function.
• Analysis of the role of adipocyte-derived factors and PVAT in vascular homeostasis.
• Examination of molecular pathways including nitric oxide (NO) bioavailability, insulin signaling, and oxidative stress.

Main Results:

• Obesity-associated PVAT inflammation alters adipo-cytokine profiles, decreasing vasodilation.
• Endothelial dysfunction in obesity involves disrupted cell junctions, increased reactive oxygen species (ROS), and inflammation mediators.
• Impaired balance between NO synthesis and ROS, altered insulin signaling, and a decreased L-arginine/asymmetric dimethyl-L-arginine (ADMA) ratio contribute to endothelial dysfunction.

Conclusions:

• Chronic inflammation in obesity significantly impairs vascular function, contributing to hypertension.
• Dysfunctional PVAT and altered adipokine signaling are critical in obesity-induced endothelial dysfunction.
• Restoring vascular homeostasis in obesity requires addressing inflammation, oxidative stress, and metabolic dysregulation.